Synopsys, Inc. (NASDAQ:SNPS) Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 47.4% in the 2nd quarter, Holdings Channel reports. The firm owned 80,035 shares of the semiconductor company’s stock after selling 72,240 shares during the period. DekaBank Deutsche Girozentrale’s holdings in Synopsys were worth $10,133,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. One Tusk Investment Partners LP increased its holdings in shares of Synopsys by 12.9% during the 2nd quarter. One Tusk Investment Partners LP now owns 35,000 shares of the semiconductor company’s stock worth $4,504,000 after buying an additional 4,000 shares during the last quarter. TD Asset Management Inc. increased its holdings in shares of Synopsys by 39.5% during the 2nd quarter. TD Asset Management Inc. now owns 183,152 shares of the semiconductor company’s stock worth $23,570,000 after buying an additional 51,882 shares during the last quarter. Pendal Group Ltd acquired a new stake in shares of Synopsys during the 2nd quarter worth approximately $616,000. Westpac Banking Corp increased its holdings in shares of Synopsys by 0.3% during the 2nd quarter. Westpac Banking Corp now owns 220,868 shares of the semiconductor company’s stock worth $28,424,000 after buying an additional 626 shares during the last quarter. Finally, Wedbush Securities Inc. increased its holdings in shares of Synopsys by 27.8% during the 2nd quarter. Wedbush Securities Inc. now owns 7,328 shares of the semiconductor company’s stock worth $943,000 after buying an additional 1,593 shares during the last quarter. Hedge funds and other institutional investors own 91.79% of the company’s stock.

Shares of NASDAQ:SNPS traded up $1.69 during mid-day trading on Friday, reaching $128.98. 860,600 shares of the company were exchanged, compared to its average volume of 857,618. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.95 and a quick ratio of 0.85. The firm has a market cap of $18.99 billion, a price-to-earnings ratio of 45.74, a P/E/G ratio of 3.80 and a beta of 1.27. The firm’s 50-day simple moving average is $133.28 and its 200 day simple moving average is $118.64. Synopsys, Inc. has a 1 year low of $79.14 and a 1 year high of $138.72.



Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, May 22nd. The semiconductor company reported $0.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.73 by $0.04. Synopsys had a net margin of 18.74% and a return on equity of 16.88%. The firm had revenue of $836.20 million during the quarter, compared to analysts’ expectations of $829.41 million. During the same quarter last year, the company posted $1.08 EPS. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, research analysts forecast that Synopsys, Inc. will post 3.03 earnings per share for the current fiscal year.

In other Synopsys news, Chairman Geus Aart De sold 156,100 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $117.15, for a total value of $18,287,115.00. Following the completion of the transaction, the chairman now owns 189,894 shares of the company’s stock, valued at approximately $22,246,082.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Chi-Foon Chan sold 5,105 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $117.15, for a total transaction of $598,050.75. Following the completion of the transaction, the chief executive officer now directly owns 204,117 shares of the company’s stock, valued at approximately $23,912,306.55. The disclosure for this sale can be found here. Insiders sold a total of 207,180 shares of company stock valued at $24,653,559 in the last three months. 1.84% of the stock is currently owned by corporate insiders.

SNPS has been the subject of a number of recent analyst reports. Bank of America restated an “average” rating on shares of Synopsys in a report on Wednesday, June 5th. BidaskClub cut shares of Synopsys from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 31st. KeyCorp increased their price objective on shares of Synopsys from $135.00 to $152.00 and gave the stock an “overweight” rating in a research report on Friday, July 12th. Wells Fargo & Co initiated coverage on shares of Synopsys in a research report on Tuesday, May 14th. They set an “outperform” rating and a $135.00 price objective for the company. Finally, Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “sell” rating and set a $143.00 price objective for the company. in a research report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. Synopsys currently has a consensus rating of “Buy” and a consensus price target of $128.00.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

See Also: What are the benefits of buying treasury bonds?

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.